Top Story
“Rx” for the Latest SCOTUS Decision on Obamacare
For the second time in three years, the Supreme Court of the United States (SCOTUS) has weighed in on key aspects of the 2010 Obamacare law, determining that regardless of whether or not a state has set up a State Exchange, uninsured citizens can now obtain subsidized care. From a business viewpoint, where does this decision leave the American Rx industry?  Tom Norton reports
...Read more

Top Story
FDA Seeks Smooth PDUFA Renewal Process
FDA has launched the process for reauthorizing the Prescription Drug User Fee Act (PDUFA), setting the stage for FDA to hear the views of patient, consumer and health professional representatives. Jill Wechsler reports
...Read more

Europe
Greece: More Than Next Week’s Medicines Supply at Risk
There are some evident challenges for pharma in the ongoing Greek crisis. But, writes Reflector, there are some less evident challenges, which may, over time, prove to be more difficult for the industry to cope with
...Read more

On the road to integration
Moving your multichannel program into the fast lane
On Demand
Join Peter Lammers and Liz Murray from Quintiles as they present insightful research findings regarding the state of the pharmaceutical industry and the use of multi-channel marketing strategies. Learn what other industries apply successfully and get different options for you to actually “make it happen” for your product.
Register for free

Investment
Confronting the Post-Grant Threat
Biopharma firms are crying foul of investment companies filing inter partes review (IPR) petitions seeking to invalidate biopharma patents. For a life sciences company that falls within an investment firm's crosshairs, an IPR has the potential to wipe out a patent critical to a drug franchise’s revenue stream, writes Brian W. Nolan
...Read more

Emerging Pharma Leaders
Pharm Exec’s Emerging Pharma Leaders 2015
The 2015 Emerging Pharma Leaders have been selected by PharmExec’s editorial staff with support from its Editorial Advisory Board. This year’s group adds to a list of more than 200 alumni dating back to June 2008. We called that first cohort of leaders “the change generation” and frankly the description remains apt today. What is different is a greater diversity in leader backgrounds and the skills required to advance to the “c-suite”
...Read more

Emerging Pharma Leaders — Slide Show
If you’re pressed for time and want just the names and faces, click here for a slide show of PharmExec’s 17 Emerging Pharma Leaders 2015
...Read more

//Paratek Pharmaceuticals, Inc. (Boston, MA) announced the appointment of Timothy Franson, M.D. to its Board of Directors. //OXiGENE, Inc. (South San Francisco, CA) appointed Matthew M. Loar as Chief Financial Officer. //Debasish Roychowdhury, M.D., who previously served as Seragon’s acting Chief Medical Officer, has been elected to the Board of Directors of Radius Health (Waltham, MA). //Dr. Gloria Matthews was named Chief Medical Officer at Histogenics Corporation (Waltham, MA). //